Save the Dates
|
ECT Certificate Course
April 17-18, 2021
This virtual course on electroconvulsive therapy (ECT) consists of didactic and practicum experiences, and concludes with an online certification exam.
Registration opens February 1st
|
|
Annual Meeting
April 24-25, 2021
Traditionally an in-person conference, this year’s event will be held virtually and is set to include plenary presentations by leading experts in the fields of ECT, TMS, and other novel brain stimulation therapies, as well as a poster session for abstract submissions. The call for abstracts is now open. Submit your work today!
Registration opens February 1st
|
Intended Audience
This year's conference is intended for practitioners, mental health professionals, and researchers of ECT and related stimulation techniques. A poster session will allow for the most recent research in ECT and other brain stimulation modalities to be presented. The information presented in this CME offering reflects the opinion of the presenters. As with all science, there may be multiple explanations for the data and multiple reasonable conclusions.
Objectives
At the conclusion of the conference, participants should be able to:
- Describe the public health value of electroconvulsive therapy.
- Review the clinical and scientific application of combining ketamine therapy with brain stimulation therapy.
- Explain the clinical and scientific application of biomarkers in brain stimulation therapy.
Continuing Education Information
This activity provides continuing education credit for physicians and psychologists. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the collaboration of AffinityCE and ISEN. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live CME activity for a maximum of 10 hours of AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AffinityCE is approved by the American Psychological Association to sponsor continuing education for psychologists. AffinityCE maintains responsibility for this program and its content. The instructional level of this activity is intermediate. The cost to participate in this CE activity is included in the activity registration fee.
Nurses and other health professionals can receive a participation certificate that states that this activity provides AMA PRA Category 1 Credit(s)TM. This may be used for continuing education credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
|
Agenda
Saturday, April 24, 2021
|
9:45a ET
|
10:00a ET
|
Welcome and Opening Remarks
Adriana Hermida, MD
|
|
|
The Public Health Value of ECT
M. Justin Coffey, MD, FAPA, CHCIO [chair]
|
|
10:00a ET
|
10:30a ET
|
ECT During the COVID Pandemic
Daniel F. Maixner, MD
|
|
10:30a ET
|
11:00a ET
|
Decreasing Suicidality in Schizophrenia: ECT Use in a City State
Phern-Chern Tor, MD
|
|
11:00a ET
|
11:30a ET
|
Who Benefits the Most: Towards Accurate Prediction of ECT Outcomes
Linda van Diermen, MD, PhD
|
|
11:30a ET
|
12:00p ET
|
Break
|
|
12:00p ET
|
12:30p ET
|
Barriers to Expanding ECT Services in the US
Samuel T. Wilkinson, MD
|
|
12:30p ET
|
1:00p ET
|
The Public Health Value of ECT Panel Q&A
|
|
1:00p ET
|
1:30p ET
|
Break
|
|
|
Brain Stimulation & Ketamine
Samuel T. Wilkinson, MD [chair]
|
|
1:30p ET
|
2:00p ET
|
Combining ECT & Ketamine to Improve Outcomes
Murat Altinay, MD
|
|
2:00p ET
|
2:30p ET
|
Ketamine & Esketamine for Treatment-Resistant Depression
Manish Jha, MBBS
|
|
2:30p ET
|
3:00p ET
|
Comparative Effectiveness of ECT vs. Ketamine
Samuel T. Wilkinson, MD
|
|
3:00p ET
|
3:15p ET
|
Brain Stimulation and Ketamine Panel Q&A
|
|
3:15p ET
|
3:45p ET
|
Break
|
|
3:45p ET
|
4:45p ET
|
Update in the Field: Brain Stimulation Nurses Panel Q&A and Networking Session
viewing of on-demand presentation prior to participation required
|
Sunday, April 25, 2021
|
9:45a ET
|
10:00a ET
|
TBD
|
|
10:00a ET
|
10:30a ET
|
ECT Pulse Amplitude and Medial Temporal Lobe Engagement
Christopher Abbott, MD
|
|
10:30a ET
|
11:00a ET
|
MRI Evidence for Hippocampus's Role in ECT Response
Amber Leaver, PhD
|
|
11:00a ET
|
11:15a ET
|
Break
|
|
11:15a ET
|
11:45p ET
|
Predicted Brain Age: Implications for Cognitive Control and TMS Response in MDD
Katharine Dunlop, PhD
|
|
11:45a ET
|
12:00p ET
|
Neuroimaging & Biomarkers Panel Q&A
|
|
12:00p ET
|
12:30p ET
|
Break
|
|
|
TMS & MST
Irving Reti, MD [chair]
|
|
12:30p ET
|
1:00p ET
|
Accelerated rTMS for Treatment-Resistant Depression
Nolan Williams, MD
|
|
1:00p ET
|
1:30p ET
|
Probing and Rescuing Dysfunctional Circuits in Depression
Connor Liston, MD
|
|
1:30p ET
|
1:45p ET
|
Break
|
|
1:45p ET
|
2:15p ET
|
TMS for Depression, PTSD and Suicide Reduction
Noah S. Philip, MD
|
|
2:15p ET
|
2:30p ET
|
TMS & MST Panel Q&A
|
|
2:30p ET
|
3:00p ET
|
Break
|
|
3:00p ET
|
4:00p ET
|
Virtual Poster Hall
Best Abstract by a Trainee Award 2020
Magnetic Seizure Therapy for the Treatment of Suicidality in Bipolar Depression and Neurophysiological Correlates of Response
Victor M. Tang, MSc, MD
Best Abstract Award 2020
The Benefits and Costs of Changing Treatment Technique in ECT Due to Insufficient Improvement: Findings from the OPT ECT Trial and from the Columbia University
Harold A. Sackeim, PhD
Best Abstract by a Trainee Award 2021
To Be Announced
Best Abstract Award 2021
To Be Announced
Best Publication, Journal of ECT Award 2020
Electroconvulsive Treatment Utilization for Inpatient Management of Severe Manic Episodes of Bipolar Disorder
Rikin S. Patel, MD, MPH
Best Publication, Journal of ECT Award 2021
To Be Announced
only presentations listed above qualify for CME credit; viewing of at least 4/6 on-demand award presentations and participation in their associated Zoom meeting is required to claim the 1 CME credit available for this session
|
Registration
REGISTRATION OPENS FEBRUARY 1, 2021
Trainee and student registrants must verify their status via an enrollment verification letter. Email such documentation to contact@isen-ect.org.
Registration Fees
| ISEN Member Physicians |
$490 USD |
| ISEN Member Other Clinicians |
$490 USD |
| ISEN Member Nurses |
$250 USD |
| ISEN Member Residents/Trainees* |
$250 USD |
| ISEN Member Students* |
$150 USD |
| ISEN Member Abstract Poster/Oral Presenters** |
$250 USD |
| Non-Member Physicians |
$870 USD |
| Non-Member Other Clinicians |
$870 USD |
| Non-Member Nurses |
$450 USD |
| Non-Member Residents/Trainees* |
$450 USD |
| Non-Member Students* |
$250 USD |
| Non-Member Abstract/Poster Oral Presenters** |
$450 USD |
*Requires status verification
Program Director letters should be mailed to contact@isen-ect.org.
**Requires acceptance of submitted abstract; one presenter per poster
Refund Policy
A refund of the registration fee, less an $85 processing fee, will be made when an email-written request followed by an email-written confirmation is received prior to April 9, 2021. After this date, refunds cannot be made. Fees will not be refunded for failure to participate. The sponsors of the course reserve the right to cancel or postpone any conference because of unforeseen circumstances or insufficient enrollment. In the event of such cancellations, full tuition will be refunded. ISEN reserves the right to refuse registration, or refund registration fees, to any person whose presence has the potential to be disruptive and/or not consistent with the mission and goals of the organization.
Virtual Events and Digital Materials
These live virtual events will be hosted via Zoom Video Webinar. Registrants will have access to program information, including slide sets received from speakers in advance of the meeting, via a password-protected page on the ISEN website.
Disclosure of Commercial Relationships
In compliance with the ACCME Standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose relevant financial interests with any commercial interests and/or non-FDA approved use of a drug or a device that is included in the presentation.
Enhancing Communication
If you require assistance with hearing or vision to make this conference accessible to you, please email meetings@isen-ect.org at least three weeks prior to the event date.
Questions? Please email: meetings@isen-ect.org
|
|
